Best Momentum Stock to Buy for March 4th

By Zacks Equity Research | March 04, 2026, 10:00 AM

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 4th:

BrightSpring Health Services, Inc. BTSG: This parent company of healthcare service lines which, provide complementary home- and community-based pharmacy and provider health solutions for complex populations in need of specialized and/or chronic care, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10% over the last 60 days.

BrightSpring Health Services, Inc. Price and Consensus

BrightSpring Health Services, Inc. Price and Consensus

BrightSpring Health Services, Inc. price-consensus-chart | BrightSpring Health Services, Inc. Quote

BrightSpring Health Services' shares gained 15.7% over the last three month compared with the S&P 500’s decline of 0.7%. The company possesses a Momentum Score of A.

BrightSpring Health Services, Inc. Price

BrightSpring Health Services, Inc. Price

BrightSpring Health Services, Inc. price | BrightSpring Health Services, Inc. Quote

XP XP: This technology-driven financial services platform which offers financial products and services primarily in Brazil, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.

XP Inc. Price and Consensus

XP Inc. Price and Consensus

XP Inc. price-consensus-chart | XP Inc. Quote

XP’s shares gained 3.2% over the last three month compared with the S&P 500’s decline of 0.7%. The company possesses a Momentum Score of A.

XP Inc. Price

XP Inc. Price

XP Inc. price | XP Inc. Quote

Catalyst Pharmaceuticals CPRX: This commercial-stage biopharmaceutical company, which is focused on the development and commercialization of therapies targeting rare and difficult-to-treat diseases, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.

Catalyst Pharmaceuticals, Inc. Price and Consensus

Catalyst Pharmaceuticals, Inc. Price and Consensus

Catalyst Pharmaceuticals, Inc. price-consensus-chart | Catalyst Pharmaceuticals, Inc. Quote

Catalyst Pharmaceuticals shares gained 3.6% over the last three month compared with the S&P 500’s decline of 0.7%. The company possesses a Momentum Score of A.

Catalyst Pharmaceuticals, Inc. Price

Catalyst Pharmaceuticals, Inc. Price

Catalyst Pharmaceuticals, Inc. price | Catalyst Pharmaceuticals, Inc. Quote

 

See the full list of top ranked stocks here

 

Learn more about the Momentum score and how it is calculated here

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Catalyst Pharmaceuticals, Inc. (CPRX): Free Stock Analysis Report
 
XP Inc. (XP): Free Stock Analysis Report
 
BrightSpring Health Services, Inc. (BTSG): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Latest News